New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
16:00 EDTOPKOPKO citicoline products approved for commercialization in Spain
OPKO Health announced that its Barcelona, Spain subsidiary, Pharmadiet, S.L.U., received regulatory approval from Spainís health authority for commercialization of its oral and injectable formulations of citicoline. Final marketing authorization is expected within 60 to 90 days.
News For OPK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 15, 2014
11:27 EDTOPKOptions with decreasing implied volatility
Options with decreasing implied volatility: EXAS INO ATLS LOCO OPK INFY EUO FDO
October 10, 2014
11:51 EDTOPKOPKO Health management to meet with Oppenheimer
Subscribe for More Information
October 9, 2014
11:17 EDTOPKOPKO investee Neovasc receives conditional approval to initiate TIARA-I trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use